Advantage Diagnostics Corp.

Advantage Diagnostics Corp. — FDA 510(k) Submissions

Advantage Diagnostics Corp. has submitted 10 FDA 510(k) premarket notifications since 1988, of which 10 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Cannabinoids, Enzyme Immunoassay, Cocaine And Cocaine Metabolites, Cannula, Surgical, General & Plastic Surgery, Enzyme Immunoassay, Opiates, Visual, Pregnancy Hcg, Prescription Use . Use the specialty filter in the sidebar to narrow results.